Pharmacological inhibition of Arg1 by 2(S)-amino-6-boronohexanoic (ABH) prevented the increase in ROS and the impairment of endothelial vasorelaxation in mouse aortic rings exposed to RBCs from patients with T2D. This evidence concerns the gene ARG1 and type 2 diabetes mellitus.